| Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor SG Holtan, AL Hoeschen, Q Cao, M Arora, V Bachanova, CG Brunstein, ... Blood Advances 4 (7), 1284-1295, 2020 | 29 | 2020 |
| Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease SG Holtan, A Shabaneh, BC Betts, A Rashidi, ML MacMillan, C Ustun, ... JCI insight 4 (17), 2019 | 28 | 2019 |
| Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical … AA Ganaie, AP Mansini, T Hussain, A Rao, HR Siddique, A Shabaneh, ... Molecular cancer therapeutics 19 (12), 2598-2611, 2020 | 12 | 2020 |
| Triple Aberrant Prostate Cancer (TAPC)-Aggregate role of aberrations in TP53, PTEN and RB1 on ETS gene fusions and prognosis in metastatic castrate resistant prostate cancer AP Watson, A Shabaneh, J Wang, SM Dehm, A Rao, CJ Ryan American journal of clinical and experimental urology 8 (4), 106, 2020 | 5 | 2020 |
| Characterization of novel murine and human PDAC cell models: identifying the role of intestine specific homeobox gene ISX in hypoxia and disease progression AA Ganaie, A Parray, T Hussain, A Shabaneh, A Jamroze, MG Ferrari, ... Translational Oncology 12 (8), 1056-1071, 2019 | 4 | 2019 |
| ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems HE Bergom, A Shabaneh, A Day, A Ali, E Boytim, S Tape, JR Lozada, ... Communications biology 6 (1), 417, 2023 | 1 | 2023 |
| Validation of an automated, scalable comprehensive genomic profiling assay for hematologic malignancies G Hogg, T Liu, H Cao, A Shafi, A Shabaneh, J Williams, J Howitt, ... Cancer Research 84 (6_Supplement), 4628-4628, 2024 | | 2024 |
| Validation of an Automated, Scalable Comprehensive Genomic Profiling Assay for Hematologic Malignancies G Hogg, T Liu, YH Cao, A Shafi, A Shabaneh, J Howitt, A Williamson, ... Blood 142, 6003, 2023 | | 2023 |
| ALAN as an omic tool to build gene signatures and to stratify patients. HE Bergom, A Day, A Shabaneh, A Ali, E Boytim, J Wang, J Hwang Journal of Clinical Oncology 41 (16_suppl), 1563-1563, 2023 | | 2023 |
| Development of a mutation profiling NGS assay to facilitate clinical decisions in hematologic malignancies G Hogg, T Liu, H Cao, A Shafi, A Shabaneh, J Howitt, A Williamson, ... Cancer Research 83 (7_Supplement), 6220-6220, 2023 | | 2023 |
| [PRE-RECORD] Distinctive Transcriptional and Microbial Signature in Cutaneous Acute Graft-Vs-Host-Disease N El Jurdi, A Shabaneh, BC Betts, A Rashidi, ML MacMillan, M Arora, ... 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | | 2022 |
| Characterizing Unmapped Reads To Decipher Microbiome Lead To Identification Of Possible Dysbiosis In Fatal Graft-Versus-Host Disease Of The Intestine A Shabaneh | | 2020 |
| Facilitating Resolution of Life-Threatening Acute Graft-vs-Host Disease with Human Chorionic Gonadotropin and Epidermal Growth Factor S Holtan, A Hoeschen, Q Cao, M Arora, V Bachanova, CG Brunstein, ... | | 2019 |
| Development and implementation of a multidisciplinary precision medicine program in ovarian cancer: A new paradigm LD Uppendahl, Z Chang, A Grad, W Lee, ZT Rivers, S Munro, Y Zhang, ... Gynecologic Oncology 154, 280-281, 2019 | | 2019 |
| RNA Sequencing of Intestinal Biopsies Expands the T Cell-Centric Paradigm of Steroid-Refractory Acute Graft-Versus-Host Disease SG Holtan, A Shabaneh, A Rashidi, BC Betts, ML MacMillan, C Ustun, ... Biology of Blood and Marrow Transplantation 25 (3), S295, 2019 | | 2019 |
| 6220. Development of a mutation profiling NGS assay to facilitate clinical decisions in hematologic malignancies G Hogg, T Liu, H Cao, A Shafi, A Shabaneh, J Howitt, A Williamson, ... | | |
